Korea's Cabinet Passes Regulations Needed For New "Drug-Pricing System"
This article was originally published in PharmAsia News
SEOUL - In a June 1 Cabinet meeting, the South Korean government approved new regulations that will enable the Ministry for Health, Welfare and Family Affairs to speed up the launch of a new "drug-pricing system" that it hopes will weed out drug rebates
You may also be interested in...
SEOUL - Last week's passage of long-awaited "anti-rebate laws" that enable courts to punish both contributors and receivers of rebates, could trigger more demand from doctors to prescribe branded products from multinational companies, industry watchers said
SEOUL - As part of its effort to root out illegal rebates, the Ministry for Health, Welfare and Family Affairs said it would launch a new "drug-pricing system" in October aimed at compensating hospitals that buy drugs at lower prices than their government-set maximum prices
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).